Advanced Cardiac Therapeutics, Inc.: Series B $5M

Posted in Q - 4Q08, R - MID ATLANTIC, R - NORTH EAST, Uncategorized, X - Anticoagulant, X - Device (Dialysis), X - Device (GI), XX - MI, XX - NH

Advanced Cardiac Therapeutics (Laguna Beach, CA) a development-stage electrophysiology and radiometry medical device company focused on energy delivery via catheters for cardiac ablation, closed a $5M Series b financing. Participants include NBGI Ventures.

Feb

2010

HistoSonics, Inc.: Series A $11M

Posted in I - Series A, Q - 1Q10, R - MID WEST, X - BPH, X - Device (Ablation), X - Histotripsy, XX - MI

HistoSonics (Ann Arbor, MI) a development stage device company focused on non-invasive image-guided tissue ablation for benign prostatic hyperplasia, closed an $11M Series A financing. Participants include Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners and TGap Ventures.

Aug

2009

Accuri Cytometers, Inc.: Series D $4M

Posted in I - Series D, Q - 3Q09, R - MID WEST, X - Device (Flow Cytometry), XX - MI

Accuri Cytometers (Ann Arbor, MI) a commercial-stage device company focused on cell analysis flow cytometry, closed a $4M Series D financing. Participants include InvestMichigan-Credit Suisse, Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures.

Jun

2009

GloStream, Inc.: Series B $7.5M

Posted in I - Series B, Q - 2Q09, R - MID WEST, X - TeleMedicine, XX - MI

GloStream (Bloomfield Hills, MI) a commercial-stgae healthcare IT company focused on electronic medical records and practice management platforms, closed on a $7.5M Series B financing. Participants include Beringea.

Jun

2009

Metabolic Solutions Development Co.: Series B $9.3M

Posted in I - Series B, Q - 2Q09, R - MID WEST, X - Diabetes, XX - MI

Metabolic Solutions Development (Kalamazoo, MI) a clinical-stage biopharmaceutical company focused on Type II diabetes, closed a $9.5M Series B financing. Participants include Southwest Michigan First Life Science Fund and Hopen Therapeutics.

May

2009

Lycera Corp.: Series A $36M

Posted in I - Series A, Q - 2Q09, R - MID WEST, X - IBD, X - Lupus, X - RA, X - Therapeutic Platform, XX - MI

Lycera Corp (Ann Arbor, MA) a preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosis and inflammatory bowel disease, closed a $36M Series A financing. Participants include InterWest Partners, ARCH Venture Partners, Clarus Ventures and EDF Ventures.

Feb

2009

NanoBio Corp.: Series B $12M

Posted in I - Series B, Q - 1Q09, R - MID WEST, X - Antiinfective, X - Therapeutic Platform, X - Vaccines, XX - MI

NanoBio (Ann Arbor, MI) a clinical-stage company focused on topical antiinfectives and mucosal vaccines for the treatment and prevention of herpes labialis, onychomycosis, acne and cystic fibrosis closed a $12M Series B financing. Participants include Perseus.

Jan

2009

Pioneer Surgical Technology, Inc.: Series B $15

Posted in I - Series B, Q - 4Q08, R - MID WEST, X - Device (Spine), XX - MI

Pioneer Surgical Technology (Marquette, MI) a commercial-stage spinal and orthopedic implant and instrument company closed a $15M Series B financing. Participants include InvestMichigan Growth Capital Fund, Pharos Capital Group, Highlander Partners, Hopewell Ventures and River Cities Capital Funds.

to top of page...